Monday, November 8, 2010

Rayleigh-Taylor Instability Surfaces, Hyperbolic Geometry, Ghost Condensates, & Three-Dimensional Magnetic Reconnection in Nuclear Physics

I put up some mp3 files from some videos in which I'd discussed some of my thoughts related to spacetime, but I took those down and will upload some of them again, as soon as I can, here. I'll link to more of the pictures, as I find the relevant ones from public-domain sources. I should be able to collect most of them. I've also linked to some segments of youtube videos.
Youtube videos:

http://www.youtube.com/watch?v=taM3mzpzw1Q [Operation Snapper: Dog Shot; May 1st, 1952; Shows transient darkening effect of spacetime distortion and so-called ghost bubble, above the detonation site, shortly after detonation; See articles on ghost bubbles, ghost radiation, ghost images, ghost emissions, etc., in relation to the astrophysics of black holes and in relation to string theory and so forth: (http://scholar.google.com/scholar?hl=en&q=ghost+%22black+hole%22+OR+quasar+OR+pulsar+OR+astrophysical+OR+Arxiv+OR+galactic&btnG=Search&as_sdt=100000001&as_ylo=&as_vis=0)]

http://www.youtube.com/watch?v=nbJdMcrJ4uA [Operation Hardtack: Shot Umbrella; Shows Rayleigh-Taylor instability "fingers," forming a jagged, teeth-like pattern, shortly after detonation; See articles on Rayleigh-Taylor fingers in magnetohydrodynamic models of supernova events and in chemical reactions, etc.: (http://scholar.google.com/scholar?hl=en&q=%22Rayleigh+taylor%22+teeth+OR+fingers&btnG=Search&as_sdt=100000001&as_ylo=&as_vis=0)]


Sarychev Volcano
[Photo from NASA, via Wikimedia Commons (http://upload.wikimedia.org/wikipedia/commons/b/be/Sarychev_Volcano.jpg); (http://www.nasa.gov/multimedia/imagegallery/image_feature_1397.html%29]



View of "caging" effect, by magnetic field lines and the dynamics of the equatorial electrojet or "electron fountain," of an equatorial nuclear detonation.


ISS020-E-09048 Sarychev
[Eruption of the Sarychev volcano, on the Kuril Islands in Russia; The photo is from NASA, via Wikimedia Commons (http://upload.wikimedia.org/wikipedia/commons/b/be/Sarychev_Volcano.jpg); (http://www.nasa.gov/multimedia/imagegallery/image_feature_1397.html%29]

This diagram shows a simplified depiction of some aspects of three-dimensional magnetic reconnection and represents different regions of spacetime as consisting of sheets, as in "world sheets," and the diagram shows the tendency for the dynamics of spacetime turnover/replication to be maximally divergent, as a consequence of the hyperbolic geometry of spacetime. Neither neutral-magnetic-flux regions (three-dimensional regions) nor the "two-dimensional" surfaces that define the regions' geometries is a region or surface that exhibits no magnetic flux. The magnetic flux lines are just organized in complex ways that can "balance out" and produce a relatively-stable (and, to some extent, symmetric, at least along some "axes") region of spacetime that isn't just a jumble or "mess" of magnetic flux lines and patterns of spacetime curvature. The "semi-neutral" regions I should note that some 3D reconnection regions are referred to as being quasi-separatrices or quasi-separatrix layers, and this means that there are sharp or "sudden" transitions or boundary surfaces between different parts of the 3D reconnection region that exhibit magnetic flux along opposing or considerably-different directions [see Aulanier et al., 2005: (http://www.aanda.org/index.php?option=com_article&access=standard&Itemid=129&url=/articles/aa/full/2005/48/aa3600-05/aa3600-05.html); (http://www.aanda.org/articles/aa/pdf/2005/48/aa3600-05.pdf)]:

Simplified view of three-dimensional magnetic reconnection, between a pair of two-dimensional, neutral-sheet surfaces, to form a neutral-sheet manifold that is shown as containing a pseudoscalar surface in a transverse plane of the manifold.

Polar (and, here, "redshifted") jets of a black hole, shown ejecting plasma blobs (i.e. buoyant bubble or "big blue bump," etc.) that could be viewed as being "entangled," in some manner, with ghost bubble in the same jets.


Post-Lightning Runaway Electron Acceleration and Dynamics of "Turnover" Waveforms Between Two Regions of Spacetime (As In "Intercloud Magnetohydrodynamics," etc.).
Here are some references on post-lightning runaway electron acceleration [Inan and Lehtinen, 2005 (see Fig. 2, p. 3 of pdf): (http://www-star.stanford.edu/~vlf/publications/2005-10.pdf); Kikuchi, 2005: (http://piers.mit.edu/piersonline/pdf/Vol1No6Page732to735.pdf); Lehtinen, Inan, and Bell, 2000 (see Fig. 3, p. 3 of pdf and p. 1097 of article): (http://nlpc.stanford.edu/nleht/Science/articles/Lehtinen+2000_Trapped_10.1029_1999GL010765.pdf)]. This new layout of the blogger software is giving me some trouble.

View of the detonation known as Operation Plumbbob: Priscilla (Photo is from the archives of the National Nuclear Security Administration's Nevada Site Office: (http://upload.wikimedia.org/wikipedia/commons/5/5b/Operation_Plumbbob_-_Priscilla_2.jpg); (http://www.nv.doe.gov/library/PhotoLibrary/57-052.jpg)]















This picture and the one below are on wikimedia commons. This picture shows a "ghost condensate" type of spacetime distortion, oriented vertically, with respect to the ground. The browser, actually, isn't letting me link to the pages to get the url to the U.S. government site [the archives of the National Nuclear Security Administration's Nevada Site Office: (http://www.nv.doe.gov/library/PhotoLibrary/57-052.jpg)]. I'll get those darn pages loaded at some point. They're big ones, I know, but I'll load 'em. It's the same source of public-domain images that I cited on the other picture(s).






[Shows the column of the mushroom cloud become invisible, transiently. Image from wikimedia commons and: (http://www.nv.doe.gov/library/PhotoLibrary/57-052.jpg)]



[This image, showing the jagged, irregular pentagonal geometry of the main jet of M87, was taken with the Hubble Space Telescope and is from NASA and the Hubble Heritage Team (STScI/AURA) (www.hubblesite.org): (http://hubblesite.org/newscenter/archive/releases/2000/20/); (http://hubblesite.org/newscenter/archive/releases/2000/20/image/a/); (http://upload.wikimedia.org/wikipedia/commons/3/39/M87_jet.jpg)]


































Tuesday, October 5, 2010

More on the Potential Relevance of Adenosine Monophosphate to the Adjunctive Management of Depression: Competition Among Nutrients for Excretion

I was just going to briefly discuss some issues that could be relevant, in my opinion, to the potential for the use of purine nucleotides and L-methylfolate, a reduced folate that is available by prescription (with the brand name of Deplin) or over-the-counter (as L-methylfolate, with the trade name of Metafolin, etc.), as adjunctive strategies, used under a doctor's supervision, for dealing with depression. The most basic thing is that the use of adenosine 5'-monophosphate (AMP) is likely to allow for more flexibility in dosing, over the long term, than the use of adenosine 5'-triphosphate (ATP) disodium is, primarily because the hydrolysis of ATP, by a variety of ectonucleotidase enzymes (and also intracellular nucleotidase enzymes, in the intestinal epithelial cells) and esterase enzymes in the luminal fluid of the small intestine, supplies significant amounts of inorganic phosphate. I don't like to mention brand names on here, and I have no financial ties whatsoever to any supplement or pharmaceutical manufacturer or to any other company or commercial interest. The Bluebonnet nucleotide complex is, in my opinion, still the only over-the-counter supplemental source of AMP that provides a meaningful amount of AMP [(http://www.google.com/products?q=nucleotide+bluebonnet&hl=en&aq=f)]. The phosphate is likely to be absorbed more rapidly than the phosphate that is derived from the hydrolysis or, rather, phosphorolysis of polyphosphates that are present in meats, for example. In my most recent postings on the nutritional aspects of phosphate, I was trying to convey that the use of supplemental sources of phosphate has the potential to be problematic, especially but not only when the supplementation continues for more than a few weeks. And I think that supplementing with any source of phosphate without close supervision by a doctor (this would be of absolutely crucial importance and would include the use of blood tests, every couple of weeks, to monitor serum phosphorus, and the use of urinary phosphorus tests to monitor urinary phosphate excretion) has the potential to be extremely hazardous. Sources of supplemental phosphate can elevate serum phosphorus in very unpredictable ways, and the key point is that AMP provides one third as much phosphate as ATP does. Some of the articles I cited in past postings show that the serum phosphorus levels can rise slowly, over many months, and then suddenly increase exponentially, with potentially devastating consequences to kidney function or to the functioning of any tissue, in which the precipitation of calcium phosphate can cause serious damage. This includes any tissue in the body. So I wanted to reiterate and strengthen my warnings about the significant potential for danger that can accompany any use, whatsoever, of a source of supplemental phosphate. Some ATP disodium supplements also contain calcium phosphate binders and silicates, and these excipients can supply significant amounts of calcium that could, in my opinion, either prevent or augment the adverse effects that excessive phosphate intakes can produce, and the effect (prevention or augmentation) would be expected to depend on the dosage and the timing of the administration/intake of the excipient. Messing around with that stuff and worrying about supplements that are loaded up with calcium doesn't sound very good to me, for reasons I've discussed, at length, in the past.

Part of the point with this is that the use of supplemental gluconate, glutamine, creatine, citrate, or adenosine or inosine or other supplements that supply organic anion substrates can, in my opinion, significantly limit the amounts of oral AMP that one can tolerate, and this can become very problematic and puzzling. I've mentioned this in the past, but I want to emphasize that it's very important, in my view, to consider the fact that many nutrients and drugs compete with phosphate and with bile acids, for example, for transport by nonspecific organic anion transporters, in the kidneys and liver. In essence, there tends to be a limit to the total supply of "organic anion transporter (OAT) substrates" (these transporters are very numerous and include the ATP-binding cassette family of transporters, and that family of transport proteins includes the multidrug resistance transport proteins, as in mdr1, mdr2, etc.) that one can ingest, and it can become necessary to "decide" which nutrient one wants to supplement with and to limit the dosages of the other OAT substrates. I've been aware of this for a long time, and many articles discuss the crucial importance of this in the context of liver disease or in relation to kidney-related pharmacology. But it took me a long time to realize that, for example, the dosages of magnesium gluconate, creatine, and glutamine that I'd been taking had been causing me to be unable to use dosages of AMP that I'd wanted to use, in relation to antidepressant augmentation, under my doctor's supervision. The dosages of the individual supplements were not high and were actually fairly low (well, I'd been taking 24 grams of glutamine and about 800 mg of creatine monohydrate, but the amounts of gluconate from magnesium gluconate are likely to have been excessively high), but the total "mass" of OAT substrates (this "mass" includes all of the citrate and glutamate and whatnot that glutamine is metabolized into, and it includes creatinine and other degradation products of creatine and also includes the extra phosphate that can accumulate intracellularly, in response to exercise, in a person who's taking creatine, given that the extra creatine phosphate can, in my opinion, tend to "dump" more phosphate during exercise) was high and was causing me to be unable to tolerate enough AMP. I was noticing that my plasma volume or, less specifically, extracellular fluid volume was high, and this was most obvious during exercise. One manifestation of this can be "water retention" that is obvious at the end of a workout, etc. Uric acid (urate) and other purines that are derived from AMP (and from the guanosine 5'-monophosphate in that nucleotide supplement) also compete with phosphate and with bile acids for transport. I've reduced the dosage of glutamine to 4-8 grams per day and reduced the dosage of creatine monohydrate to about 400 or 500 mg per day (I may reduce this further) and have been able to tolerate more AMP, etc. I also stopped taking magnesium gluconate. If one were taking a small dose of magnesium gluconate, this might not be an issue. But what's a small dose. To supply 30 mg of magnesium, one has to take in something like a gram of gluconate (derived from the magnesium gluconate, after one has ingested it).

This is a very important issue, in my opinion, because AMP is, in my view, probably the most "important" over-the-counter compound that could, in my view, be of sigificance in relation to adjunctive antidepressant strategies that researchers could test and that one could discuss with one's doctor. Methylfolate, for example, has the potential, in my view, to gradually contribute to the decreases in the intracellular purine nucleotide levels that can result, in my opinion, from the use of any number of medications that produce any sort of excitatory effect, whatsoever, on neurotransmission. On a personal level, I've found that none of the antidepressant augmentation strategies, such as Deplin (prescription L-methylfolate), has been nearly as useful, in the long term, without the concomitant use of AMP, but that's just been my experience. It's important to remember that the accumulation of uric acid, produced by purine degradation, can become problematic in the long term and could, in my opinion, contribute to soft tissue calcification, and the safe way to go would be to monitor one's urinary uric acid levels and not just to monitor serum uric acid (serum urate) levels with blood tests. The "excitation-induced decrease in purine nucleotide concentrations" in neurons and astrocytes is a general phenomenon and could even occur in response to the pathological, stress-induced increases in the firing rates of noradrenergic neurons in the locus ceruleus or other adrenergic cell groups (i.e. the A1, A2, and A3-A6 and C1, etc., adrenergic cell groups in different parts of the medulla oblongata). I'll try to put up some better references, but here are some of the countless articles discussing the neuronal-excitation-induced increases in extracellular fluid adenosine levels [Latini and Pedata, 2001: (http://www.blackwellpublishing.com/specialarticles/jnc607.pdf); Rosenberg and Li, 1995: (http://www.ncbi.nlm.nih.gov/pubmed/8548307); Schubert et al., 1997: (http://www.ncbi.nlm.nih.gov/pubmed/9369970); Matsumoto et al., 1982: (http://www.ncbi.nlm.nih.gov/pubmed/1352728); Hagberg et al., 1987: (http://www.ncbi.nlm.nih.gov/pubmed/3585332); Frenguelli et al., 2007: (http://www.ncbi.nlm.nih.gov/pubmed/17459147)(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920548/pdf/jnc0101-1400.pdf); Hagberg et al., 1986: (http://www.ncbi.nlm.nih.gov/pubmed/2875423)]. When there's the kind of excessive noradrenergic transmission that can lead to the derangements and "decreases" in noradrenaline (norepinephrine) "levels" that have been associated with the worsening of depression or of anxiety disorders, there is the distinct potential, in my opinion, for increases in glutamate release, by glutamatergic neurons that provide synaptic inputs to the noradrenergic or dopaminergic or serotonergic neurons, to also occur and to have the potential to contribute to the excessive increases, as can be induced by stress, in the firing rates of the noradrenergic neurons or other groups of neurons.

The point is that, in my opinion, exogenous AMP, for example, has the potential to replenish some of these losses, even if the effect is not as great as one would like it to be (as it would be in response to intravenous inosine, for example, or an adenosine prodrug or source of intravenous adenosine that would release adenosine very, very slowly into the bloodstream). But I can't make any statements about the efficacy or safety of any of these supplements, and I definitely wouldn't expect any of the supplements to be effective by themselves, without conventional prescription medications, in the treatment of depression or anything else. I'll reiterate the extreme importance of discussing these details and concepts with your doctor.

Monday, October 4, 2010

Another Poem

Remember

You look
Around
And
Write your notes and
Walk around
And
Are
In and out
Before
I can see
Your eyes,
Under the lights,
Seeing,
The way you see
DVDs,
Alone,
On any of the quiet days
That we've been
Far away from each other.
I can never
Reach you
Or
See you,
Even though I try
So hard to remember
Your face.
I don't think
Anyone
Can memorize
A fire
And picture every arc and spiral
And whisper of the
Hottest mystery
That consumes the things
That
I remember
And that were
There
In the beginning
And that
I don't want to
Forget.

Sunday, October 3, 2010

Poem

Magic Key

In the Fall,
I remember the empty bench
That you
Took a picture of
And asked me to
Wait to sit on
With you
Because you couldn't
Help
Falling
In love with me.
All the leaves
Look sickly,
And all
The bright and busy bees
That buzz around in the Spring
Are gone.
And all
The golden colors
Of the Fall
Are gone
And piled up in rotting bags,
Ready to be burned
Into nothing.
Every
Thing
You
Are
Is
Magic.

Friday, June 25, 2010

Down in the Valley

Way down in the valley,
Down the swirling steps,
Through the spinning rapids,
Among the sparkling stones,
On the glitter-gumdrop river,
You rolled along the currents
And met me where the water
Slows and spreads across the plain.
We watched,
Together,
As the jagged
Canyon
City
Came tumbling
Down
Around us
And crumbled in the desert.
When the sun
Was setting,
The river
Flowed
Up the crystal wall
Waterfall,
Over the iron
Cliffs, past the
Places where the
Animals
Roam and run,
And
Your eyes
Are
Roaring
Lions
That
Let us
Ride
Up and over
The red clay
Gym-classs
Springboard
Country.

Thursday, June 24, 2010

Doming in a Ferryl-to-Ring Charge Transfer Complex

It's noteworthy that I attempted to showcase the "bright magenta" or "bright fuchsia" color, in the positive-phase lobes of the atomic orbitals and molecular orbitals (MOs), but the program only allowed for a "poppy red" color in these diagrams. I wasn't aware that poppies were red, but what do I know. These diagrams show the formation of a ferryl-to-ring charge-transfer complex, as part of a "charge-transfer state" or "charge-transfer electronic state," to allow for an electron transition to occur, and this transition is from one of the two roughly-degenerate, highest-occupied MOs (in this case--and as is usually the case in iron(IV)-hemes--these are the pi*xz and pi*yz antibonding MOs) to the lowest-unoccupied molecular orbital of the porphyrin ring that can be found in this particular electronic state (a state that I haven't defined here) of an iron(IV)-heme. In this case, it's one of the two eg(pi*) antibonding MOs (A and B, a.k.a. x and y) that tend to combine, through configuration interaction, into a new pair of MOs (one that is produced by constructive interaction and another that's produced through destructive overlap). The eg(A+B) and eg(A-B) configuration-interaction MOs actually appear to be quite similar, and the MO I drew might not actually be the true LUMO of the porphyrin moiety (it might be the eg(A-B)). It's noteworthy that the egA(pi*) and egB(pi*) MOs do not exhibit the same "appearance" in "Cartesian Coordinate System 1" as they do in "Cartesian Coordinate System 2," as I've named the two "systems" [see here: (http://hardcorephysiologyfun.blogspot.com/2010/05/occupancies-of-frontier-orbitals-of.html)]. I've redrawn the MOs from Fig. 9A, on p. 124, of the article by Hocking et al. (2007) [Hocking et al., 2007: (http://www.anorg.chem.uu.nl/PDF/hocking%20JACS2007.pdf)(http://www.ncbi.nlm.nih.gov/pubmed/17199290)], in coordinate system 1, instead of depicting them in the less-commonly-used coordinate system 2, with the x and y axes intersecting the nitrogen atoms of the pyrrole moieties of the porphyrin ring, that Hocking et al. (2007) show in Fig 9. The doming of the porphyrin ring normally occurs for very brief durations, such as less than one picosecond, during the catalytic cycles of heme-dependent enzymes. A "charge transfer" is basically just a one-electron transfer from a highest-occupied molecular orbital of one molecule or moiety of a molecule to a lowest-unoccupied molecular orbital of another molecule or of another moiety, within a single molecule. In this case, the ferryl moiety is undergoing a one-electron oxidation by the porphyrin ring.





Friday, June 4, 2010

ATP Consumption by Acute Increases in the Activities of Acyl-CoA Synthetases or Aminoacyl-tRNA Synthetases: Potential Relevance to Depression Research

In the abstract of this article [Capecchi et al., 1997: (http://www.ncbi.nlm.nih.gov/pubmed/9546959)], the authors discuss their finding that the administration, presumably intravenously, of either acetyl-L-carnitine (ALCAR) or propionyl-L-carnitine increased plasma concentrations of adenosine and ATP. I can't get the full text of that article, but I think that's relevant to an understanding of the apparent "plateauing" of (or even decreases in) the supposed mood-elevating effects of triacetyluridine at higher dosages [Jensen et al., 2008: (http://www.ncbi.nlm.nih.gov/pubmed/18540779)] and also to an understanding of the potential mechanisms by which high dosages of acetyl-L-carnitine might, in my opinion, worsen mood, even as lower dosages may produce a neutral effect or very, very slight beneficial effect, in that regard (though it seems that the main rationale for the use of acetyl-L-carnitine would be to increase beta-oxidation of fatty acids and to slightly augment mitochondrial functioning, by limiting the accumulation of fatty acyl-CoA thioesters that tend to inhibit the activities of mitochondrial enzymes, etc.). Although the authors of several articles have found some evidence that ALCAR elevates mood in elderly people, I wouldn't expect much in that regard. But hey, that's just my opinion. A little joke. There's a lot of research that shows the capacity of ethanol ingestion to elevate plasma acetate in humans [Puig and Fox, 1984: (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC425250/)(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC425250/pdf/jcinvest00135-0276.pdf); (http://scholar.google.com/scholar?hl=en&q=acetate+ethanol+AMP+adenosine&btnG=Search&as_sdt=100000000)], and that effect of ethanol could produce transient mood elevation but also produce a worsening of mood in the "intermediate term" or longer term. In one explanation for that effect of ethanol, the oxidation of ethanol to acetaldehyde and to acetate increases the availability of free acetate (and increases plasma acetate and, concomitantly, increases the rate of urinary excretion of oxypurines, which are hypoxanthine and xanthine and urate/uric acid) (Puig and Fox, 1984) and thereby increases ATP consumption, as the free acetate serves as a substrate of acetyl-CoA synthetase and undergoes conversion into acetyl-CoA. The key point in many articles is that the rapid influx of acetate or another short-chain fatty acid (such as butyrate or one of the most-commonly-encountered ketones, beta-hydroxybutyrate and acetoacetate) or even longer-chain fatty acids, in theory, can consume enough ATP to significantly deplete the adenine nucleotide pools of cells and increase plasma urate, as ethanol can. Some of the older articles that discuss the capacity of acetate to induce ATP depletion, by increasing ATP turnover (consumption and also rephosphorylation of ADP and AMP and free adenosine and inosine and hypoxanthine) use the term "acetate thiokinase" to refer to acetyl-CoA synthetase [Ballard, 1972: (http://www.ncbi.nlm.nih.gov/pubmed/4558368)(http://www.ajcn.org/cgi/reprint/25/8/773.pdf)]. I cited this article by Vamecq et al., 2005 [Vamecq et al., 2005: (http://www.ncbi.nlm.nih.gov/pubmed/15713528)] in a past posting, and Vamecq et al. (2005) discussed the potential capacity for rapid increases in ketone or free-fatty-acid availability to increase ATP consumption and thereby, potentially, contribute to the supposed therapeutic effects of "ketogenic" diets (see p. 13, Fig. 4, along with other parts of the article). It's interesting that Ballard (1972) cited research (see column 1, p. 775, refs. 22 and 23) showing that the inhibition of TCA cycle enzymes or, by implication, inhibition of respiration per se, given that decreases in ADP availbility or in the availability of inorganic phosphate exacerbated the effect, had been shown to increase the accumulation of free acetate in in vitro or ex vivo experiments. That could, presumably, occur because a decrease in ATP availability would be expected to decrease the rate of acetyl-CoA formation. It's interesting that phosphate can, evidently, limit the accumulation of free acetate, presumably by vitrtue of its inhibitory effect on adenosine deaminase activity (thereby limiting purine degradation and loss from the cells) [not a good search, but: (http://scholar.google.com/scholar?hl=en&q=phosphate+inorganic+%22adenosine+deaminase%22+OR+%22Adenylic+Acid+Deaminase%22&btnG=Search&as_sdt=100000000&as_ylo=&as_vis=0)]. Anyway, the point is that the deacetylation (esterolysis, etc.) of triacetyluridine may yield significant amounts of acetate, and this might mean that higher dosages could begin to cause meaningful increases in ATP consumption, in my opinion. At lower dosages, the acetate-mediated elevations in extracellular adenosine could contribute to the supposed mood-elevating effects of triacetyluridine. In my experience, the "beneficial" effects of triacetyluridine are not nearly as significant when the triacetyluridine is taken in the absence of oral adenosine monophosphate or ATP disodium, etc. Those supplements haven't been proven to produce mood-elevating effects, however, and could worsen the moods of some people, and one would, obviously, want to discuss this type of thing with one's doctor. It's interesting that 2'-O-acetyl-ADP-ribose and 3'-O-acetyl-ADP ribose (and also ADP that contains di-O-acetylated ribose) are produced endogenously (http://scholar.google.com/scholar?hl=en&q=ADP-ribose+acetyl+ribose&btnG=Search&as_sdt=100000000&as_ylo=&as_vis=0). Maybe that endogenous formation of acetylated ribose (triacetyluridine is 2', 3',5'-tri-O-acetyluridine) allows for the formation of some "ribosyl" adducts of lysine or other amino acid residues on proteins to occur spontaneously and limit the potential for O-acetylated nucleoside prodrugs to become antigenic, as discussed in past postings. Another thing is that some researchers have suggested that the rapid influx of some free amino acids could cause ATP depletion by increasing the aminoacyl-tRNA synthetase-dependent consumption of ATP, in the formation of aminoacyl-tRNAs. It's conceivable that the supposed advantages of the use of L-glutamine as an energy substrate are partially a result of the (presumably) lower activities of enzyme(s) that exhibit glutaminyl-tRNA synthetase activity, in comparison to the activities of other aminoacyl-tRNA synthetase enzymes. There could also, conceivably, be a lag time, of some length of hours or days, before some kind of steady-state increases in the pool of glutaminyl-tRNA occur, in response to the administration of exogenous L-glutamine (http://scholar.google.com/scholar?hl=en&q=glutaminyl-tRNA+eukaryotic+OR+human&btnG=Search&as_sdt=100000000&as_ylo=&as_vis=0). The full ATP-buffering effects that glutamine might, conceivably, produce might not occur immediately, given the potential for glutaminyl-tRNA synthetase enzymes to consume ATP. But I think that that would be much more likely to be an effect that amino acids other than glutamine would have. It's interesting that some or maybe all aminoacyl-tRNA synthetases are zinc dependent, and some researchers have investigated the potential significance of the zinc-mediated activation of aminoacyl-tRNA synthetase enzymes and consequent increases in ATP turnover or depletion [see Plateu et al., 1981: (http://scholar.google.com/scholar?hl=en&q=aminoacyl-tRNA+synthetase+ATP+depletion+OR+consumption&btnG=Search&as_sdt=100000000&as_ylo=&as_vis=0)].